Table 3.

Classification of trials by sponsor status and phase of development

	Phase I and I/II	Phase II and II/III	Phase III	Phase not specified	Total
Commercial	124 (20.5%)	85 (32.6%)	35 (53.8%)	4 (44.4%)	248 (26.4%)
Non-commercial	480 (79.5%)	174 (66.6%)	30 (46.2%)	3 (33.4%)	687 (73.2%)
Sponsor not specified		2 (0.8%)		2 (22.2%)	4 (0.4%)
Total	604 (64.3%)	261 (27.9%)	65 (6.9%)	9 (0.9%)	939 (100%)

Notes: The table shows the number of trials sponsored by a commercial and non-commercial sponsor and the sponsor status in each phase of development.